GET THE APP

Journal of Hematology & Thromboembolic Diseases

Journal of Hematology & Thromboembolic Diseases
Open Access

ISSN: 2329-8790

+44 1478 350008

Namarata Pal

Department of Biotechnology, India

Publications
  • Review Article   
    Acute Lymphoblastic leukemia (ALL)
    Author(s): Namarata Pal*

    Leukaemia as we know is a malignant cancer of the bone marrow and blood which is characterized by an uncontrolled accumulation of abnormal blood cells which leads to the inhibition of normal blood cells functions and many times death. It causes more deaths than any other form cancer among children around the age of twenty [1]. Acute lymphoblastic is a cancer of white blood cells which fight against infection characterized by the excessive multiplication of malignant and immature WBC (lymphoblast) in bone marrow. This cancer can be treated by chemotherapy, steroids, radiation therapy and intensive combined treatments including bone marrow or stem cell transplants. The drugs which are commonly used for this cancer are prednisolone, dexamethasone, vincristine, L-asparaginase, daunorubicin, cyclophosphamide,cytarabine, etoposide, thioguanine, mercaptopurine, hydrocortisone, etc. There are.. View More»
    DOI: 10.35248/2329-8790.21.9.331

    Abstract HTML PDF

Top